Vedolizumab

ATC L04AG05 · 10 markets · 32 records

Vedolizumab 10 markets · 32 records Forms

AU 8 records · 5 strengths

  • 108 mg/0.68 mLinjectionENTYVIO also in GB·US·SG
  • 300 mginjectionENTYVIO also in GB·ES·TW
  • 331.2 mginjectionENTYVIO vedolizumab 300 mg powder for injection vialKYNTELES vedolizumab (rch) 300 mg powder for injection vial unknown
  • 119 mginjectionENTYVIO vedolizumab 108 mg/0.68 mL solution for injection pre-filled penENTYVIO vedolizumab 108 mg/0.68 mL solution for injection pre-filled syringe unknown

Records without a stated strength · 1 Entyvio IV、ENTYVIO Pen

GB 4 records · 2 strengths

US 3 records · 2 strengths

CA 3 records · 2 strengths

HK 3 records · 1 strengths

    Records without a stated strength · 1 Entyvio Powder for Concentrate for Solution for Infusion、ENTYVIO SOLUTION FOR INJECTION IN PRE-FILLED PEN 108MG/0.68ML、ENTYVIO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 108MG/0.68ML

    SG 2 records · 2 strengths

    ES 2 records · 2 strengths

    TW 2 records · 2 strengths

    MX 1 records · 1 strengths

      Records without a stated strength · 1 ENTYVIO SC

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 ENTYVIO

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.